Pioneer of Polio Eradication

Total Page:16

File Type:pdf, Size:1020Kb

Pioneer of Polio Eradication COMMENT SPRING BOOKS MEDICAL HISTORY Pioneer of polio eradication Tilli Tansey extols a biography of determined of Pittsburgh in Pennsylva- vaccine trailblazer Jonas Salk. nia. Harry Weaver, research director of the National Foundation for Infantile n 12 April tenacity that shaped Paralysis (NFIP), invited 1955, across both his scientific him to work on typ- the United success and his pro- ing polio viruses and, OStates, “church bells fessional difficulties. eager for space, staff tolled, horns honked, Early on, at the New and equipment, Salk and sirens rang” in York University Col- accepted. He made rapid celebration: the larg- lege of Medicine, Salk progress, refining and est clinical trial ever worked with influenza replacing contemporary undertaken had expert Thomas Francis. methodologies — often in the reported that the first Jonas Salk: A Life At the time, antiviral vaccines face of criticism or even prohibi- polio vaccine was safe CHARLOTTE DECROES (against smallpox, rabies and yellow tion from the NFIP advisory commit- JACOBS and effective. So writes Oxford Univ. Press: fever) used artificially weakened live virus. tee. Weaver supported his protégé, and the Charlotte Jacobs in 2015. Salk and Francis developed an experimental foundation came to see Salk as its ‘poster her riveting biogra- technique that used killed virus to stimulate scientist’, wheeled out for public and media phy of the vaccine’s discoverer, Jonas Salk. antibody production and confer immunity, events. Fellow researchers continued to carp. Two years earlier, poliomyelitis had killed suggesting a powerful therapeutic approach. Undeterred, Salk pioneered a killed-virus or paralysed almost 36,000 US children. It In 1941, Salk followed Francis to Michi- vaccine and organized safety testing and has been estimated that before the vaccine gan, pursuing the holy grail — an influenza field trials. Those leading up to the 1955 there were 600,000 cases a year worldwide. vaccine. He modified laborious procedures announcement involved more than 1.5 mil- Salk’s triumph made him a global household to culture the virus and develop vaccine pro- lion children, tens of thousands of doctors name, and the gongs began rolling in. duction, usually with only gloves and a mask and nurses, and 220,000 volunteers. The As Jacobs shows, the tale of Salk’s discovery as protection. He supervised clinical tests on clamour attendant on success (a film was is one of grind, intrigue, rivalry, politics and patients at two psychiatric institutions, delib- mooted, to star Marlon Brando) laid Salk dirty tricks. Add commercial interests (phar- erately infecting some with influenza — a open to charges of self-aggrandisement. maceutical giant Eli Lilly made US$30 mil- practice common until the Nuremberg Code Almost immediately, problems arose. lion from polio vaccine in 1955 alone) and of 1947 offered some protection to human Batches of vaccine became contaminated, Salk’s extramarital entanglements while research subjects — and in 1945 advised the and physicians inoculated family and friends wedded to artist (and muse to Pablo Picasso) US surgeon general to vaccinate 8 million while leaving first-grade children, the most Françoise Gilot, and the mix becomes even soldiers. Without consulting Francis, Salk vulnerable group, unprotected. Over a few headier. Jacobs contextualizes the polio effort signed an exclusive contract with pharma- months, 260 individuals contracted polio with Salk’s work on influenza, multiple scle- ceutical firm Parke, Davis to provide details directly or indirectly from a single substand- rosis and HIV/AIDS — and with the Salk of production methods that he devised. This ard preparation. Several states suspended Institute for Biological Studies in La Jolla, departure from academic etiquette did not vaccination. Massachusetts halted its pro- California, which he created and directed, go unnoticed; nor did his writing for non- gramme when children had received only the and from which he was ultimately excluded. professional publications such as Parents first of three shots; in July 1955, some 4,000 Growing up in the Bronx, New York, in a Magazine. Tensions grew as Francis received contracted polio and 1,700 were paralysed. family of Russian Jewish immigrants, Salk honours, while Salk was ignored. Salk was unfairly associated with these errors was dominated by his ambitious mother. He In 1947, Jacobs recounts, Salk left to and was castigated, especially by scientific came to crave doing things his own way — a establish an influenza lab at the University colleagues. However, tighter adherence to his Water 4.0 The Tale of the Duelling Neurosurgeons David Sedlak YALE UNIV. PRESS 2015 Sam Kean BLACK SWAN 2015 From Roman aqueducts to desalinization plants, Crammed with curious anecdotes from David Sedlak’s study overflows with facts about neuroscience’s gory past, Sam Kean’s book water management. Chlorine by-products could ranges from the crude methods of early brain be carcinogens, so he argues that water treatment studies (including the beheading of criminals to needs another upgrade. (See Margaret Catley- use as test subjects) to the prion disease kuru, Carlson’s review: Nature 505, 288–289; 2014.) which spreads through cannibalism. 620 | NATURE | VOL 520 | 30 APRIL 2015 © 2015 Macmillan Publishers Limited. All rights reserved SPRING BOOKS COMMENT protocols and resumption of vaccination meant that six years after the vaccine was introduced, polio was almost eradicated in the United States. Much of the scientific establishment closed ranks against Salk. He was given the prestigious Lasker Award for clinical medi- cal research in 1956, but Swedish virologist Sven Gard dealt his Nobel nomination a fatal blow by sneering that the vaccine was a technical advance, not a discovery. Nor was Salk elected to the US National Acad- emy of Sciences. Virologist Albert Sabin — bombastic, imperious and galled by Salk’s success — continued to develop a live, orally delivered poliovirus preparation. By 1961, Sabin’s vaccine had performed well in trials and the American Medical Asso- ciation began to promote it. Salk’s vaccine was, for a time, superseded, and his efforts to improve its potency stymied. Salk moved on, although he remained involved with the polio vaccine. Influenced by chemist C. P. Snow’s 1959 book The Two Cultures and the Scientific Revolution, he launched a research institute integrating social responsibility and the humanities with the biological sciences. The Salk Insti- tute recruited some of the great biologists of the time, including Jacob Bronowski, Francis Crick and Jacques Monod. But Salk was unable to translate his lofty ideals into practical management. His research from the 1960s onwards, on immune responses in cancer, multiple sclerosis and, PHYSICS later, HIV/AIDS, met with ambivalence. He was increasingly derided by the very scientists whom he had recruited. In many ways, Salk was ahead of his One hundred years of time, notably in public engagement and in his multidisciplinary agenda. A polio vaccine would have emerged without him, general relativity but it was his vision and willpower that produced the first, and a descendant of it Pedro Ferreira looks back at how Einstein himself and a is still the basis of many public-health pro- panoply of other physicists have framed the theory. grammes. Yet universal polio eradication remains a dream: cases continue to appear in Pakistan, Afghanistan and Nigeria, and ntil very recently, relativists were universes and black holes, you were left to have resurged in recent years in Syria. ■ few and often self-taught. General your own devices. That is what happened relativity still had the stigma of to me. Tilli Tansey is professor of the history of Ubeing esoteric, pointless and, well, hard. I studied engineering and did not enjoy modern medical sciences at Queen Mary, In some places you could find special- it very much. But during the course on University of London. ized graduate courses, but on the whole, electromagnetism, I discovered Albert e-mail: [email protected] if you were at all interested in expanding Einstein’s world of special relativity. Tesla: Inventor of the Electrical Age Infinitesimal: How a Dangerous Mathematical W. Bernard Carlson PRINCETON UNIV. PRESS 2015 Theory Shaped the Modern World Over-hyped eccentric or electricity wizard? Bernard Amir Alexander ONEWORLD 2015 Carlson’s account of Nikola Tesla’s life at the turn of the Through religious and revolutionary figures of twentieth century recalls the inventor’s great creations, the seventeenth century, Amir Alexander tells the such as the alternating-current motor, as well as the history of the struggle for mathematics’ place in unfulfilled promise of wireless power. (See Patrick society. The ‘heretical’ concept of infinitesimals, McCray’s review: Nature 497, 562–563; 2013.) the indivisible points of a line, takes centre stage. 30 APRIL 2015 | VOL 520 | NATURE | 621 © 2015 Macmillan Publishers Limited. All rights reserved.
Recommended publications
  • A Guide to Preparing Multiple Choice Items
    A Guide to Preparing Multiple Choice Items Introduction The most commonly used type of test item in admissions, certification, and licensure examinations is the multiple choice item. The purpose of this guide is to assist test developers and representatives of professional associations in becoming more skilled in writing multiple choice test items. Preparing multiple choice items may appear on the surface to be a relatively simple task, given familiarity with the subject matter. However, experienced test authors find that this task actually requires a great deal of skill, patience, and creativity. In the sections that follow, general knowledge is used as the content of the examples, in order to facilitate understanding of the principles by professionals from diverse content areas. The skills needed for writing quality items are similar regardless of content discipline. Like any other skill, multiple choice item writing requires a significant amount of painstaking practice with appropriate feedback. It is essential that you try out your multiple choice items on others. This process will help you to uncover ambiguities in wording and unintended violations of item writing principles. Feedback from others will greatly enhance your item writing quality and productivity. Parts of the Multiple Choice Item All multiple choice items consist of two basic parts: the stem and the responses. The stem is the introductory statement or question that elicits the correct answer. The responses are suggested answers which complete the statement or answer the question asked in the stem, only one of which is the correct answer. In the examples that follow, four responses (i.e., 1 correct response and 3 incorrect responses) are presented.
    [Show full text]
  • Jonas Salk at the National Press Club, April 12, 1965
    Jonas Salk at the National Press Club, April 12, 1965 Jonas Salk, May 1962. A.F.P. – D.P.A. Photos. National Press Club Archives On the tenth anniversary of the licensing of the polio vaccine he developed, Dr. Jonas E. Salk (1914-1995) visited Washington to accept a joint congressional resolution that hailed the vaccine as “one of the most significant medical achievements of our time.” At the White House, President Johnson offered Salk his congratulations. The day also marked the twentieth anniversary of the death of former President Franklin D. Roosevelt, who, having suffered from paralytic polio since 1921, had established the foundation that funded Salk’s efforts. Following his meetings with Congress and the President, Salk gave a talk and answered reporters’ questions at a National Press Club luncheon. In the title of its lead editorial ten years earlier celebrating the successful testing of the new vaccine, the New York Times proclaimed the “Dawn of a New Medical Day.” Testing of the vaccine, like the funding for its development, had engaged the participation of millions of ordinary American citizens. Through March of Dimes campaigns, hundreds of thousands of volunteers went door-to-door raising $41 million in 1952 alone from average donations of 27 cents. The tests involved 1.8 million school children, 200,000 volunteers, 64,000 teachers, and 60,000 physicians, nurses, and health officials, making it the largest clinical trial in history. Interpreting the jubilant 1 reaction to news that the vaccine had been proven safe and effective, the Times commented, “Gone are the old helplessness, the fear of an invisible enemy, the frustration of physicians.” Poliomyelitis, also known as infantile paralysis, is an extremely contagious viral infection caused by any of three types of poliovirus.
    [Show full text]
  • Poliomyelitis in the Lone Star State
    POLIOMYELITIS IN THE LONE STAR STATE: A BRIEF EXAMINATION IN RURAL AND URBAN COMMUNITIES THESIS Presented to the Graduate Council of Texas State University in Partial Fulfillment of the Requirements For the Degree Master of Arts By Jason C. Lee San Marcos, Texas December, 2005 Insert signature page here ii COPYRIGHT By Jason Chu Lee 2005 iii ACKNOWLEDGEMENTS It leaves me in a stupor to contemplate all those I have to thank for aiding me in this effort. If I leave anybody out, please accept my most humble apologies, as the list is long. I will be the first to admit that this work is flawed, despite the best efforts of my committee to save me from myself. Had I utilized them more, this piece would only be improved. I had never undertaken a project of this scope before and though I believe I have accomplished much, the experience has been humbling. Never again will I utter the phrase, “just a thesis.” My biggest thanks go out to Dr. Mary Brennan, my committee chair and mentor. Without her guidance I most certainly would have needed to take comprehensive finals to graduate. She helped me salvage weeks of research that I thought had no discernable use. But Dr. Brennan, despite her very, very busy schedule with the department and her family, still found the time to help me find my thesis in all the data. She is well loved in the department for obvious reasons, as she has a gift for being firm and professional while remaining compassionate. Dr. James Wilson and Dr.
    [Show full text]
  • COVID-19 Eradication for Vaccine Equity in Low Income Countries
    Perspective COVID-19 Eradication for Vaccine Equity in Low Income Countries DHANYA DHARMAPALAN,1 T JACOB JOHN2 From 1Pediatric Infectious Diseases, Apollo Hospitals, CBD Belapur, Navi Mumbai, Maharashtra; 2Chairman, Child Health Foundation, Vellore, Tamil Nadu. Correspondence to: Dr. Dhanya Dharmapalan, Consultant in Pediatric Infectious Diseases, Apollo Hospitals, CBD Belapur, Navi Mumbai 400 614, Maharashtra. [email protected]. PII: S097475591600340 Note: This early-online version of the article is an unedited manuscript that has been accepted for publication. It has been posted to the website for making it available to readers, ahead of its publication in print. This version will undergo copy-editing, typesetting, and proofreading, before final publication; and the text may undergo minor changes in the final version INDIAN PEDIATRICS 1 JUNE 09, 2021 [E-PUB AHEAD OF PRINT] DHANYA DHARMAPALAN, T JACOB JOHN COVID-19 ERADICATION ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic will transition into endemic phase with perpetual risk of severe disease and high mortality in vulnerable people – the elderly and those with co-morbidities, unless eradicated. Although several vaccines are already available to rich countries, low-income countries face gross vaccine inequity. We propose COVID-19 eradication to address both problems. An eradication program will ensure vaccine equity and international cooperation to establish public health surveillance and high quality laboratory diagnostic services in all countries. Eradication is biologically and technically feasible. We hope the World Health Organization will accept the proposition and design the necessary strategy without delay. Keywords: Herd effect, Herd immunity, SARS-CoV-2. Severe Acute Respiratory Syndrome (SARS) caused by SARS Coronavirus type 1 (SARS-CoV-1) began spreading within China in November, 2002, became pandemic in March 2003, and affected 29 countries, with 8096 cases and 774 deaths [1].
    [Show full text]
  • Vaccine Symposium Louis Pasteur As Pioneers Who Fundamentally Changed the Nature of Presented by the MSU Department of Microbiology & Immunology Human Health
    Maurice Hilleman, 1919-2005, was a 1941 MSU graduate who saved the lives of millions by developing a wide array of vaccines. nd 2 Maurice Hilleman A Miles City native, Hilleman graduated atop his class at what was then Montana State College with dual degrees in chemistry and microbiology. His name often accompanies those of Jonas Salk and Vaccine Symposium Louis Pasteur as pioneers who fundamentally changed the nature of Presented by the MSU Department of Microbiology & Immunology human health. The abstract on a National Institutes of Health obituary for Hilleman describes him this way: "Microbe hunter, pioneering virologist, and the world's leading vaccinologist." Mi Among Hilleman's scientific achievements: • A hepatitis B vaccine that was the first vaccine to prevent a cancer in humans (liver cancer, or hepatoma). • A measles-mumps-and-rubella combination vaccine chat marked the first time vaccines for different viruses were successfully combined in a single shot. • Vaccines for meningitis and pneumonia. • A mumps vaccine that came after Hilleman isolated the virus by swabbing the back of his daughter Jeryl Lynn's throat when she was stricken with the disease (50 years later it is still the basis for most mumps vaccines). • A more complete understanding of the ways different strains of the flu change slightly from year to year, which led to the practice of developing an annual seasonal flu vaccine. • The first successful prediction of a coming influenza pandemic and development of a vaccine that thwarted it, 2018 possibly saving close to a million people in 1957. Indeed, Hilleman was responsible for developing 8 out of the 14 recommended vaccinations today.
    [Show full text]
  • Re-Thinking Pandemics: State, Society, and Disease in British History, 1830-1960
    Providence College DigitalCommons@Providence History & Classics Undergraduate Theses History & Classics Spring 2021 Re-thinking Pandemics: State, Society, and Disease in British History, 1830-1960 Meghan Walsh Follow this and additional works at: https://digitalcommons.providence.edu/history_undergrad_theses Part of the European History Commons, and the History of Science, Technology, and Medicine Commons Re-thinking Pandemics: State, Society, and Disease in British History, 1830-1960 by Meghan Walsh HIS 490 History Honors Thesis Department of History and Classics Providence College Spring 2021 This thesis is dedicated to the 3 million people who lost their lives to COVID-19 and to all the frontline workers and essential employees, without whom nothing would be possible. “Epidemics all follow this similar arc where people deny or dismiss the threat until it becomes impossible to ignore any more,” - Mark Honigsbaum, medical historian at City, University of London CONTENTS ACKNOWLEDGEMENTS………………………………………………………………………vi INTRODUCTION …………………………………………...……………………………………1 CHAPTER 1: THE STORY OF CHOLERA ……………………………………………………..8 CHAPTER 2: IGNORING INFLUENZA………………………………………………………..23 CHAPTER 3: TREATING POLIO ……………………………………………………………...36 CONCLUSION: HOW THINGS HAVE CHANGED…………………………………………...54 BIBLIOGRAPHY.........………………………………………………………………………….59 v ACKNOWLEDGEMENTS A project this size truly takes a village, and I am eternally grateful to mine for seeing me through to the end of this. Researching and immersing myself in the lives and experiences of British citizens from three major pandemics, whilst living in one, was an interesting journey, but several people ensured I never went on it alone. To Dr. Smith and Dr. Murphy, thank you for making this possible and for granting me the opportunity to write a senior thesis. Your comments, guidance and encouragement were invaluable.
    [Show full text]
  • The March of Dimes and Polio: Lessons in Vaccine Advocacy for Health Educators
    Feature Article The March of Dimes and Polio: Lessons in Vaccine Advocacy for Health Educators Dawn Larsen ABSTRACT The polio vaccine became available in 1955, due almost entirely to the efforts of the March of Dimes. In 1921, Franklin Roosevelt gave a public face to polio and mounted a campaign to prevent it, establishing the National Foundation for Infantile Paralysis in 1938. During the Depression, U.S. citizens were asked to contribute one dime. Entertainer Eddie Cantor suggested the name the March of Dimes, paraphrasing the popular newsreel “The March of Time.” Jonas Salk advocated a killed-virus vaccine while Albert Sabin proposed a live-virus vaccine. Both competed for both recognition and funding from the March of Dimes. In 1955 Salk’s vaccine was adopted, nationwide vaccination programs were implemented, and polio rates dropped by 80 percent. In 1961, Sabin’s vaccine, endorsed by the American Medical Association, became the vaccine of choice. The World Health Assembly advocated polio eradication by the year 2000. By 2004 eradication efforts were threatened by allegations linking vaccines to chronic diseases. Immunization dropped and polio resurfaced in the U.S., Australia, Africa and Russia. Research linking vaccines to chronic disease was dis- credited, but vaccine opponents remain active. Health educators are well positioned to mitigate damage caused by the anti-vaccine movement and address barriers to immunization efforts. Larsen D. The March of Dimes and polio: lessons in vaccine advocacy for health educators. Am J Health Educ. 2012;43(1):47-54. Submitted May 30, 2011. Accepted July 9, 2011. In 2008, The March of Dimes cel- prenatal health promotion programs, and of the virus that has been ranked second ebrated its 70th anniversary.
    [Show full text]
  • Morbidity and Mortality Weekly Report
    Morbidity and Mortality Weekly Report Weekly February 13, 2004 / Vol. 53 / No. 5 Outbreaks of Avian Influenza A (H5N1) in Asia and Interim Recommendations for Evaluation and Reporting of Suspected Cases — United States, 2004 During December 2003–February 2004, outbreaks of highly In Thailand, influenza A (H5N1) infection was confirmed pathogenic avian influenza A (H5N1) among poultry were in four males, aged 6–7 years, and one female, aged 58 years. reported in Cambodia, China, Indonesia, Japan, Laos, South All five patients died (1). Other cases are under investigation. Korea, Thailand, and Vietnam. As of February 9, 2004, a total of 23 cases of laboratory-confirmed influenza A (H5N1) virus Analysis of Viruses infections in humans, resulting in 18 deaths, had been reported Antigenic analysis and genetic sequencing distinguish in Thailand and Vietnam. In addition, approximately 100 sus- between influenza viruses that usually circulate among birds pected cases in humans are under investigation by national and those that usually circulate among humans. Sequencing health authorities in Thailand and Vietnam. CDC, the World of the H5N1 viruses obtained from five persons in Vietnam Health Organization (WHO), and national health authorities and Thailand, including one sister from the cluster in Viet- in Asian countries are working to assess and monitor the situ- nam, has indicated that all of the genes of these viruses are of ation, provide epidemiologic and laboratory support, and avian origin. No evidence of genetic reassortment between assist with control efforts. This report summarizes informa- avian and human influenza viruses has been identified. If tion about the human infections and avian outbreaks in Asia reassortment occurs, the likelihood that the H5N1 virus can and provides recommendations to guide influenza A (H5N1) be transmitted more readily from person to person will surveillance, diagnosis, and testing in the United States.
    [Show full text]
  • August 2021 Factsheet Access to Vaccines
    ACCESS TO HEALTHCARE AND PRICING ACCESS TO VACCINES GRI Standards : 416-1, 416-2 : Customer Health and Safety EXECUTIVE SUMMARY Vaccines have a great impact on public health. The World Health Organization considers immunization to be one of the most effective and cost-effective health interventions. It has eradicated smallpox, reduced the global incidence of polio by 99% to date,1 and dramatically reduced morbidity, disability and mortality due to diphtheria, tetanus, pertussis, tuberculosis and measles. Despite these important achievements, there is still a long way to go: 19.7 million children worldwide still have no access to a full cycle of basic vaccines.2 Due to lower immunization coverage in some countries, we are witnessing a resurgence of diseases that had almost disappeared, such as measles or pertussis. This affects people around the world, including in high-income countries. True to its vision of a world where no one suffers or dies from a vaccine-preventable disease, Sanofi Pasteur is committed to improve sustainable access to vaccines, with the help of key partnerships to provide effective and affordable vaccines and protection for all populations. This document presents some of our key commitments and initiatives illustrating our longstanding dedication to global access to health through prevention and vaccination. 1 WHO Factsheet on Poliomyelitis, last updated July 2019. https://www.who.int/news-room/fact-sheets/detail/poliomyelitis 2 WHO Factsheet on Immunization, last updated July 2020. https://www.who.int/en/news-room/fact-sheets/detail/immunization-coverage Access to Vaccines Factsheet 1 Published August 2021 TABLE OF CONTENTS 1.
    [Show full text]
  • INFLUENZA VIRUS VACCINE THREE YEARS EXPERIENCE in the U. 8. ARMY by LT. COL. T. G. FAISON Ojke of the Surgeon General, Washingto
    INFLUENZA VIRUS VACCINE THREE YEARS EXPERIENCE IN THE U. 8. ARMY By LT. COL.T. G. FAISON Ojke of the Surgeon General, Washington, D. C. It is a pleasure and privilege to be able to meet with the United States- Mexico Border Public Health Association. Rapid transportation has increased the need for cooperative action in the field of national and international health. The vectors and agents of disease do not respect international boundaries or treaties. 1 have always been impressed by the amicable international relation- ship between doctors, other scientific men and especially public health personnel. The results of this friendly and cooperative attitude have been most beneficial to mankmd. For the three year period 1945 to 1948, the U. S. Army required the inoculation of al1 troops with influenza virus vaccine. The vaccine con- tained 50% Type B (Lee), 25% Type A PR8, and 25% A Prime (Weiss or FMl) strains. The decision to vaccinate was based largely upon the signifkant results obtained in evaluation studies of influenza virus vaccine during 1943 and 1945** 2, 3. Since 1945, evaluation studies con- ducted by the Commission on Influenza of the Army Epidemiological Board and other investigators have not been in satisfactory agreement as to results which would determine the advisability of its use4* 6* 6* l. In 1946-1947 and again in 1947-1948, reports show that the influenza vaccine which was given afforded no protection against the type of in- l Francis, Thomas; Jonas Salk; and William M. Brace: The Protective Effect of Vaccination Against Epidemic Influenza B, Jour.
    [Show full text]
  • Polio Laboratory Manual
    WHO/IVB/04.10 ORIGINAL: ENGLISH Polio laboratory manual 4th edition, 2004 The World Health Organization has managed The evaluation of the impact of vaccine- cooperation with its Member States and preventable diseases informs decisions to provided technical support in the fi eld of introduce new vaccines. Optimal strategies vaccine-preventable diseases since 1975. and activities for reducing morbidity and In 2003, the offi ce carrying out this function mortality through the use of vaccines are was renamed the WHO Department of implemented (Vaccine Assessment and Immunization, Vaccines and Biologicals. Monitoring). The Department’s goal is the achievement Efforts are directed towards reducing fi nancial of a world in which all people at risk are and technical barriers to the introduction protected against vaccine-preventable of new and established vaccines and diseases. Work towards this goal can be immunization-related technologies (Access to visualized as occurring along a continuum. Technologies). The range of activities spans from research, development and evaluation of vaccines Under the guidance of its Member States, to implementation and evaluation of WHO, in conjunction with outside world immunization programmes in countries. experts, develops and promotes policies and strategies to maximize the use and delivery WHO facilitates and coordinates research of vaccines of public health importance. and development on new vaccines and Countries are supported so that they immunization-related technologies for viral, acquire the technical and managerial skills, bacterial and parasitic diseases. Existing competence and infrastructure needed to life-saving vaccines are further improved and achieve disease control and/or elimination new vaccines targeted at public health crises, and eradication objectives (Expanded such as HIV/AIDS and SARS, are discovered Programme on Immunization).
    [Show full text]
  • Poliomyelitis and the Salk Vaccine
    Poliomyelitis and the Salk Vaccine Table of Contents Preface......................................................................................................................................................................................................... 2 Center for the History of Medicine ......................................................................................................................................................... 2 Introduction ................................................................................................................................................................................................. 3 Collections .................................................................................................................................................................................................. 5 1 Return to Table of Contents Preface The Bentley Historical Library and the Historical Center for the Health Sciences (now the Center for the History of Medicine), with support from the Southeast Michigan Chapter of the March of Dimes Birth Defects Foundation, collaborated to commemorate the 40th anniversary of the announcement that the poliomyelitis vaccine developed by Dr. Jonas Salk was safe and effective. As part of the commemoration, a printed guide was prepared to highlight and illustrate the archival and manuscript holdings in the Bentley Historical Library relating to polio and the development and the testing of the Salk vaccine. In the period since the guide was published,
    [Show full text]